Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where P.D. Howes is active.

Publication


Featured researches published by P.D. Howes.


Journal of Medicinal Chemistry | 2007

Optimization of novel acyl pyrrolidine inhibitors of hepatitis C virus RNA-dependent RNA polymerase leading to a development candidate

M.J. Slater; E.M. Amphlett; D.M. Andrews; G. Bravi; George Burton; A.G. Cheasty; John Andrew Corfield; M.R. Ellis; R. Fenwick; S. Fernandes; Rossella Guidetti; David Haigh; C.D. Hartley; P.D. Howes; Deborah Lynette Jackson; Richard L. Jarvest; Victoria Lucy Helen Lovegrove; Katrina Jane Medhurst; Nigel R. Parry; H. Price; P. Shah; O.M.P. Singh; R. Stocker; Pia Thommes; C. Wilkinson; A. Wonacott


Journal of Hepatology | 2007

[594] GSK625433; A NOVEL AND HIGHLY POTENT INHIBITOR OF THE HCV NS5B POLYMERASE

F. Gray; E.M. Amphlett; H. Bright; L. Chambers; A.G. Cheasty; R. Fenwick; David Haigh; D. Hartley; P.D. Howes; Richard L. Jarvest; F. Mirzai; F. Nerozzi; Nigel R. Parry; M.J. Slater; Stephen A. Smith; Pia Thommes; C. Wilkinson; E. Williams


Archive | 2003

1-acyl-pyrrolidine derivatives for the treatment of viral infections

David GlaxoSmithKline Haigh; Charles David Hartley; P.D. Howes; Deborah Lynette Jackson; Pritom Shah; Martin John GlaxoSmithKline Slater


Archive | 2005

4-methoxymethyl-pyrrolidine-2-carboxylic acid compounds and derivatives thereof as hepatitis c virus inhibitors

Rossella Guidetti; David GlaxoSmithKline Haigh; Charles David Hartley; P.D. Howes; F. Nerozzi; Stephen Allan Smith


Abstracts Of Papers Of The American Chemical Society | 2007

Identification of GSK625433: A novel clinical candidate for the treatment of hepatitis C.

David Haigh; E.M. Amphlett; G. Bravi; H. Bright; V. Chung; C.L. Chambers; A.G. Cheasty; M.A. Convery; M.R. Ellis; R. Fenwick; D.F. Gray; C.D. Hartley; P.D. Howes; Richard L. Jarvest; Katrina Jane Medhurst; A. Mehbob; D. Mesogiti; F. Mirzai; F. Nerozzi; Nigel R. Parry; N. Roughley; T. Skarzynski; M.J. Slater; Stephen A. Smith; R. Stocker; C.J. Theobald; P.J. Thomas; Pia Thommes; J.H. Thorpe; C. Wilkinson


Archive | 2006

Preparation of 4-(methoxycarbonyl)pyrrolidine-2-carboxylic acid derivatives as hepatitis C virus inhibitors.

Rossella Guidetti; David Haigh; C.D. Hartley; P.D. Howes; F. Nerozzi; Stephen A. Smith


Archive | 2007

Preparation of azolylmethylpyrrolidinecarboxylates for treating viral infections

David Haigh; C.D. Hartley; P.D. Howes; Richard L. Jarvest; Linos Lazarides; F. Nerozzi; Stephen A. Smith


Archive | 2007

2-Heteroarylmethyl-4-pyrazin-2-yl-N-acyl pyrrolidine compounds as antiviral agents, their preparation, pharmaceutical compositions, and use for treatment of hepatitis C.

David Haigh; C.D. Hartley; P.D. Howes; Linos Lazarides; F. Nerozzi; Stephen A. Smith


Archive | 2006

Preparation of 4-(pyrazin-2-yl)pyrrolidine-2-carboxylic acid derivatives as hepatitis C virus inhibitors.

Rossella Guidetti; David Haigh; C.D. Hartley; P.D. Howes; F. Nerozzi; Stephen A. Smith


Archive | 2004

Synthesis of 1-acyl-pyrrolidine derivatives for the treatment of viral infections.

David Haigh; C.D. Hartley; P.D. Howes; Deborah Lynette Jackson; P. Shah; M.J. Slater

Collaboration


Dive into the P.D. Howes's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

F. Nerozzi

University of California

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge